Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R) #ElitePharma #Lisdex #Vyvanse #Chemicals #Pharmaceutical #HealthCare #Medical #Pharmaceuticals #OTC #OTCMarkets #OTCStocks #Investing
Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite's generic version of Vyvanse® (Lisdexamfetamine Disylate) with strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg capsules. The product is indicated for the treatment of attention deficit hyperactivity disorder (ADHD). This product...
http://dlvr.it/TH14cG
http://dlvr.it/TH14cG
Comments
Post a Comment